Phase III trial of Sci-B-Vac

Trial Profile

Phase III trial of Sci-B-Vac

Planning
Phase of Trial: Phase III

Latest Information Update: 13 Jul 2017

At a glance

  • Drugs Hepatitis B vaccine recombinant (Primary)
  • Indications Hepatitis B
  • Focus Registrational; Therapeutic Use
  • Acronyms CONSTANT
  • Most Recent Events

    • 13 Jul 2017 New trial record
    • 11 Jul 2017 According to a VBI Vaccinesmedia release, the company had a positive discussions with the U.S. Food & Drug Administration (FDA), the European Medicines Agency (EMA), and Health Canada for the conduct of this study.
    • 11 Jul 2017 According to a VBI Vaccinesmedia release, the initiating enrollment in this study in the second half of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top